Development and validation of a laryngopharyngeal reflux questionnaire, the Pharyngeal Reflux Symptom Questionnaire

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 2, 2010, Pages 147-159

  Andersson, Olle ^a   Rydén, Anna ^b   Ruth, Magnus ^a,b   Möller, Riitta Ylitalo ^c   Finizia, Caterina ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Laryngopharyngeal reflux; Questionnaire; Validation

Indexed keywords

ANALYTICAL ERROR; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LARYNGOPHARYNGEAL REFLUX; MAJOR CLINICAL STUDY; MALE; PHARYNGEAL REFLUX SYMPTOM QUESTIONNAIRE; PRIORITY JOURNAL; RELIABILITY; SCORING SYSTEM; SHORT FORM 36; VALIDATION STUDY;

AGED; COUGH; DEGLUTITION; DEGLUTITION DISORDERS; FEMALE; HEALTH SURVEYS; HOARSENESS; HUMANS; MALE; MIDDLE AGED; PHARYNGITIS; QUALITY OF LIFE; QUESTIONNAIRES; REGURGITATION, GASTRIC;

EID: 76749131058     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365520903453166     Document Type: Article

References (20)

1. Jaspersen D, Kulig M, Labenz J, Leodolter A, Lind T, Meyer-Sabellek W, et al. Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther 2003;17:1515-1520 (Pubitemid 36831442)
2. Vakil N, Van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20; quiz 1943.
3. Jaspersen D, Labenz J, Willich SN, Kulig M, Nocon M, Leodolter A, et al. Long-term clinical course of extra-oesophageal manifestations in patients with gastrooesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study. Dig Liver Dis 2006;38:233-238
4. Andersson O, Moller RY, Finizia C, Ruth M. A more than 10-year prospective, follow-up study of esophageal and pharyngeal acid exposure, symptoms and laryngeal findings in healthy, asymptomatic volunteers. Scand J Gastroenterol 2009;44:23-31.
5. Branski RC, Bhattacharyya N, Shapiro J. The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease. Laryngoscope 2002;112:1019-1024
6. Noordzij JP, Khidr A, Desper E, Meek RB, Reibel JF, Levine PA. Correlation of pH probe-measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis. Laryngoscope 2002;112:2192-2195
7. Ylitalo R, Lindestad PA, Ramel S. Symptoms, laryngeal findings, and 24-hour pH monitoring in patients with suspected gastroesophago-pharyngeal reflux. Laryngoscope 2001;111:1735-1741
8. Qadeer MA, Phillips CO, Lopez AR, Steward DL, Noordzij JP, Wo JM, et al. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a metaanalysis of randomized controlled trials. Am J Gastroenterol 2006;101:2646-2654
9. Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice 2002;16:274-277
10. Dauer E, Thompson D, Zinsmeister AR, Dierkhising R, Harris A, Zais T, et al. Supraesophageal reflux: validation of a symptom questionnaire. Otolaryngol Head Neck Surg 2006;134:73-80.
11. Carrau RL, Khidr A, Gold KF, Crawley JA, Hillson EM, Koufman JA, et al. Validation of a quality-of-life instrument for laryngopharyngeal reflux. Arch Otolaryngol Head Neck Surg 2005;131:315-320
12. Andersson O, Rydén A, Ruth M, Ylitalo R, Finizia C. Validation of the Swedish translation of LPR-HRQL. Unpublished work, 2009.
13. Taft C, Karlsson J, Sullivan M. Performance of the Swedish SF-36 version 2.0. Qual Life Res 2004;13:251-256
14. Ware JE, Jr., Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998;51:903-912
15. Nunally J, Bernstein I. Psychometric theory. New York: McGraw Hill; 1994.
16. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297-334.
17. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101 (4 Pt 2 Suppl 53):1-78.
18. Eryuksel E, Dogan M, Golabi P, Sehitoglu MA, Celikel T. Treatment of laryngopharyngeal reflux improves asthma symptoms in asthmatics. J Asthma 2006;43:539-542
19. Carrau RL, Khidr A, Crawley JA, Hillson EM, Davis JK, Pashos CL. The impact of laryngopharyngeal reflux on patient-reported quality of life. Laryngoscope 2004;114:670-674 (Pubitemid 38548778)
20. Patrick DL, Chiang YP. Measurement of health outcomes in treatment effectiveness evaluations: conceptual and methodological challenges. Med Care 2000;38(9 Suppl): II14-25.